Cargando…
The Design of Alapropoginine, a Novel Conjugated Ultrashort Antimicrobial Peptide with Potent Synergistic Antimicrobial Activity in Combination with Conventional Antibiotics
(1) Background: Antimicrobial resistance represents an urgent health dilemma facing the global human population. The development of novel antimicrobial agents is needed to face the rising number of resistant bacteria. Ultrashort antimicrobial peptides (USAMPs) are considered promising antimicrobial...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231522/ https://www.ncbi.nlm.nih.gov/pubmed/34199154 http://dx.doi.org/10.3390/antibiotics10060712 |
_version_ | 1783713443814047744 |
---|---|
author | Salama, Ali Almaaytah, Ammar Darwish, Rula M. |
author_facet | Salama, Ali Almaaytah, Ammar Darwish, Rula M. |
author_sort | Salama, Ali |
collection | PubMed |
description | (1) Background: Antimicrobial resistance represents an urgent health dilemma facing the global human population. The development of novel antimicrobial agents is needed to face the rising number of resistant bacteria. Ultrashort antimicrobial peptides (USAMPs) are considered promising antimicrobial agents that meet the required criteria of novel antimicrobial drug development. (2) Methods: Alapropoginine was rationally designed by incorporating arginine (R), biphenylalanine (B), and naproxen to create an ultrashort hexapeptide. The antimicrobial activity of alapropoginine was evaluated against different strains of bacteria. The hemolytic activity of alapropoginine was also investigated against human erythrocytes. Finally, synergistic studies with antibiotics were performed using the checkerboard technique and the determination of the fractional inhibitory index. (3) Results: Alapropoginine displayed potent antimicrobial activities against reference and multi-drug-resistant bacteria with MIC values of as low as 28.6 µg/mL against methicillin-resistant S. aureus. Alapropoginine caused negligible toxicity toward human red blood cells. Moreover, the synergistic studies showed improved activities for the combined conventional antibiotics with a huge reduction in their antimicrobial concentrations. (4) Conclusions: The present study indicates that alapropoginine exhibits promising antimicrobial activity against reference and resistant strains of bacteria with negligible hemolytic activity. Additionally, the peptide displays synergistic or additive effects when combined with several antibiotics. |
format | Online Article Text |
id | pubmed-8231522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82315222021-06-26 The Design of Alapropoginine, a Novel Conjugated Ultrashort Antimicrobial Peptide with Potent Synergistic Antimicrobial Activity in Combination with Conventional Antibiotics Salama, Ali Almaaytah, Ammar Darwish, Rula M. Antibiotics (Basel) Article (1) Background: Antimicrobial resistance represents an urgent health dilemma facing the global human population. The development of novel antimicrobial agents is needed to face the rising number of resistant bacteria. Ultrashort antimicrobial peptides (USAMPs) are considered promising antimicrobial agents that meet the required criteria of novel antimicrobial drug development. (2) Methods: Alapropoginine was rationally designed by incorporating arginine (R), biphenylalanine (B), and naproxen to create an ultrashort hexapeptide. The antimicrobial activity of alapropoginine was evaluated against different strains of bacteria. The hemolytic activity of alapropoginine was also investigated against human erythrocytes. Finally, synergistic studies with antibiotics were performed using the checkerboard technique and the determination of the fractional inhibitory index. (3) Results: Alapropoginine displayed potent antimicrobial activities against reference and multi-drug-resistant bacteria with MIC values of as low as 28.6 µg/mL against methicillin-resistant S. aureus. Alapropoginine caused negligible toxicity toward human red blood cells. Moreover, the synergistic studies showed improved activities for the combined conventional antibiotics with a huge reduction in their antimicrobial concentrations. (4) Conclusions: The present study indicates that alapropoginine exhibits promising antimicrobial activity against reference and resistant strains of bacteria with negligible hemolytic activity. Additionally, the peptide displays synergistic or additive effects when combined with several antibiotics. MDPI 2021-06-13 /pmc/articles/PMC8231522/ /pubmed/34199154 http://dx.doi.org/10.3390/antibiotics10060712 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Salama, Ali Almaaytah, Ammar Darwish, Rula M. The Design of Alapropoginine, a Novel Conjugated Ultrashort Antimicrobial Peptide with Potent Synergistic Antimicrobial Activity in Combination with Conventional Antibiotics |
title | The Design of Alapropoginine, a Novel Conjugated Ultrashort Antimicrobial Peptide with Potent Synergistic Antimicrobial Activity in Combination with Conventional Antibiotics |
title_full | The Design of Alapropoginine, a Novel Conjugated Ultrashort Antimicrobial Peptide with Potent Synergistic Antimicrobial Activity in Combination with Conventional Antibiotics |
title_fullStr | The Design of Alapropoginine, a Novel Conjugated Ultrashort Antimicrobial Peptide with Potent Synergistic Antimicrobial Activity in Combination with Conventional Antibiotics |
title_full_unstemmed | The Design of Alapropoginine, a Novel Conjugated Ultrashort Antimicrobial Peptide with Potent Synergistic Antimicrobial Activity in Combination with Conventional Antibiotics |
title_short | The Design of Alapropoginine, a Novel Conjugated Ultrashort Antimicrobial Peptide with Potent Synergistic Antimicrobial Activity in Combination with Conventional Antibiotics |
title_sort | design of alapropoginine, a novel conjugated ultrashort antimicrobial peptide with potent synergistic antimicrobial activity in combination with conventional antibiotics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231522/ https://www.ncbi.nlm.nih.gov/pubmed/34199154 http://dx.doi.org/10.3390/antibiotics10060712 |
work_keys_str_mv | AT salamaali thedesignofalapropoginineanovelconjugatedultrashortantimicrobialpeptidewithpotentsynergisticantimicrobialactivityincombinationwithconventionalantibiotics AT almaaytahammar thedesignofalapropoginineanovelconjugatedultrashortantimicrobialpeptidewithpotentsynergisticantimicrobialactivityincombinationwithconventionalantibiotics AT darwishrulam thedesignofalapropoginineanovelconjugatedultrashortantimicrobialpeptidewithpotentsynergisticantimicrobialactivityincombinationwithconventionalantibiotics AT salamaali designofalapropoginineanovelconjugatedultrashortantimicrobialpeptidewithpotentsynergisticantimicrobialactivityincombinationwithconventionalantibiotics AT almaaytahammar designofalapropoginineanovelconjugatedultrashortantimicrobialpeptidewithpotentsynergisticantimicrobialactivityincombinationwithconventionalantibiotics AT darwishrulam designofalapropoginineanovelconjugatedultrashortantimicrobialpeptidewithpotentsynergisticantimicrobialactivityincombinationwithconventionalantibiotics |